Lee's Pharmaceutical Holdings Limited reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was HKD 368.34 million compared to HKD 337.33 million a year ago. Net income was HKD 13.84 million compared to HKD 25.02 million a year ago. Basic earnings per share from continuing operations was HKD 0.0235 compared to HKD 0.0425 a year ago. Diluted earnings per share from continuing operations was HKD 0.0235 compared to HKD 0.0425 a year ago. For the nine months, sales was HKD 952.39 million compared to HKD 894.04 million a year ago. Net income was HKD 2,169.04 million compared to HKD 122.01 million a year ago. Basic earnings per share from continuing operations was HKD 3.6852 compared to HKD 0.2075 a year ago. Diluted earnings per share from continuing operations was HKD 3.6834 compared to HKD 0.2074 a year ago.